Northwest Biotherapeutics Inc Sustainability Reports
Northwest Biotherapeutics, Inc. is a biotechnology company focused on developing personalized immunotherapy products for the treatment of various cancers. Its lead program involves DCVax dendritic cell-based vaccines tailored to combat solid tumors.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
LEI: 5493002DRWWEOWTT8005
FIGI: BBG001S7FZT6
2 reports from 2010 to 2017
